Xiao M. Zhang
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Editorial: Exploring herpesviruses: from biology to disease management and prevention.
Journal: Frontiers in immunology
Published: July 22, 2026
Enhanced rhLCV production in lymphoblastoid cell lines derived from rhLCV-infected cynomolgus macaque PBMCs.
Journal: Journal of virology
Published: January 27, 2026
Effective Amelioration of Alzheimer's Disease in Preclinical Models With Electrophilic Compounds via Nrf2 Pathway Activation.
Journal: Journal of biochemical and molecular toxicology
Published: November 25, 2025
The growing interests in Epstein-Barr virus: A bibliometric analysis of research trends, collaborations, and emerging hotspots.
Journal: Infectious medicine
Published: April 24, 2025
Micronutrient antioxidant supplementation alleviates valproic acid-induced oxidative stress and male infertility via the NRF2/HO-1 pathway.
Journal: Redox biology
Published: April 10, 2025
Therapeutic potential of monomethyl fumarate and aluminum ion combination in alleviating inflammation and oxidative stress in psoriasis.
Journal: Redox biology
Published: November 12, 2024
Epstein-Barr virus-mediated immune evasion in tumor promotion.
Journal: Trends in immunology
Published: October 31, 2024
TianTan vaccinia virus-based EBV vaccines targeting both latent and lytic antigens elicits potent immunity against lethal EBV challenge in humanized mice.
Journal: Emerging microbes & infections
Published: October 10, 2024
Prophylactic vaccines against Epstein-Barr virus.
Journal: Lancet (London, England)
Published: July 29, 2024
Nrf2-mediated ferroptosis inhibition: a novel approach for managing inflammatory diseases.
Journal: Inflammopharmacology
Published: June 01, 2024
A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection.
Journal: Nature communications
Published: September 20, 2023
Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes.
Journal: Emerging microbes & infections
Published: August 05, 2023
Last Updated: 09/26/2026